Uploaded November 2022 | Updated November 2026, 15 hours ago
Generic and biosimilar medicines have generated more than $2.6 trillion in savings for patients over the past 10 years. With increased patient access, those savings will only continue to increase.
Learn more in our 2022 #GRxBiosims Savings Report: bit.ly/3UnZc7G
Generic and biosimilar medicines have generated more than $2.6 trillion in savings for patients over the past 10 years. With increased patient access, those savings will only continue to increase.
Learn more in our 2022 #GRxBiosims Savings Report: bit.ly/3UnZc7G










